Clinical trial • Phase I • Oncology
KO-2806 for Pancreatic ductal adenocarcinoma | Colorectal cancer | Non-small cell lung cancer | Renal cell carcinoma
Phase I trial of KO-2806 for Pancreatic ductal adenocarcinoma | Colorectal cancer | Non-small cell lung cancer | Renal cell carcinoma.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Pancreatic ductal adenocarcinoma | Colorectal cancer | Non-small cell lung cancer | Renal cell carcinoma
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 30-09-2024
- First CTIS Authorization Date
- 30-01-2025
Trial design
None/Not specified-controlled Phase I trial across 16 sites in France, Germany, Italy and others.
- Comparator
- None/Not specified
- Target Sample Size
- 234
Eligibility
Recruits 234 Vulnerable population selected; no details on consent or assent available in the provided documents..
- Vulnerable Population
- Vulnerable population selected; no details on consent or assent available in the provided documents.
Recruitment
- Planned Sample Size
- 234
- Recruitment Window Months
- 35
- Consent Approach
- No information on informed consent or assent process available in provided documents.
Geography
- Total Number Of Sites
- 16
- Total Number Of Participants
- 66
France
- Earliest CTIS Part Ii Submission Date
- 21-01-2025
- Latest Decision Or Authorization Date
- 20-04-2026
- Processing Time Days
- 454
- Number Of Sites
- 4
- Number Of Participants
- 15
Sites
- Site Name
- Assistance Publique Hopitaux De Paris
- Department Name
- Oncologie Médicale
- Contact Person Name
- Paul GOUGIS
- Contact Person Email
- Paul.gougis@aphp.fr
- Site Name
- Oncopole Claudius Regaud
- Department Name
- Oncologie Médicale
- Contact Person Name
- Audrey RABEAU
- Contact Person Email
- Rabeau.audrey@iuct-oncopole.fr
- Site Name
- Centre Leon Berard
- Department Name
- Oncologie Médicale
- Contact Person Name
- Philippe CASSIER
- Contact Person Email
- Philippe.cassier@lyon.unicancer.fr
- Site Name
- Assistance Publique Hopitaux De Paris
- Department Name
- Oncologie Médicale
- Contact Person Name
- Jacques MEDIONI
- Contact Person Email
- Jacques.medioni@aphp.fr
Germany
- Earliest CTIS Part Ii Submission Date
- 07-01-2025
- Latest Decision Or Authorization Date
- 10-03-2026
- Processing Time Days
- 427
- Number Of Sites
- 3
- Number Of Participants
- 8
Sites
- Site Name
- Universitaetsklinikum Wuerzburg AöR
- Department Name
- Interdisziplinäres Studienzentrum
- Contact Person Name
- Barbara Deschler-Baier
- Contact Person Email
- ISZ_Koordination@ukw.de
- Site Name
- Charite Universitaetsmedizin Berlin KöR
- Department Name
- Med. Klinik m.S. Hämato-Onkologie
- Contact Person Name
- Sebastian Ochsenreither
- Contact Person Email
- sebastian.ochsenreither@charite.de
- Site Name
- Universitaetsklinikum Ulm AöR
- Department Name
- Comprehensive Cancer Center Ulm (CCCU) – Early Clinical Trials Unit (ECTU)
- Contact Person Name
- Friedemann Zengerling
- Contact Person Email
- Friedemann.Zengerling@uniklinik-ulm.de
Italy
- Earliest CTIS Part Ii Submission Date
- 07-01-2025
- Latest Decision Or Authorization Date
- 09-03-2026
- Processing Time Days
- 426
- Number Of Sites
- 5
- Number Of Participants
- 27
Sites
- Site Name
- IRCCS Istituto Nazionale Tumori Fondazione Pascale
- Department Name
- Ricerca Traslazionale a Servizio dei percorsi oncologici
- Contact Person Name
- Adriano Gravina
- Contact Person Email
- a.gravina@istitutotumori.na.it
- Site Name
- Istituto Di Candiolo Fondazione Del Piemonte Per L'Oncologia IRCCS
- Department Name
- SC Oncology
- Contact Person Name
- Vanessa Gregorc
- Contact Person Email
- vanesa.gregorc@ircc.it
- Site Name
- Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
- Department Name
- Oncology and Haematology
- Contact Person Name
- Stefania Salvagni
- Contact Person Email
- stefania.salvagni@aosp.bo.it
- Site Name
- Humanitas Mirasole S.p.A.
- Department Name
- U.O di Oncologia Medica ed Ematologia
- Contact Person Name
- Agnese Losurdo
- Contact Person Email
- agnese.losurdo@humanitas.it
- Site Name
- Centro Ricerche Cliniche Di Verona S.r.l.
- Department Name
- Oncology Section
- Contact Person Name
- Andrea Zivi
- Contact Person Email
- andrea.zivi@aovr.veneto.it
Spain
- Earliest CTIS Part Ii Submission Date
- 07-01-2025
- Latest Decision Or Authorization Date
- 16-03-2026
- Processing Time Days
- 433
- Number Of Sites
- 4
- Number Of Participants
- 16
Sites
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- University Hospital Virgen Del Rocio S.L.
- Department Name
- Oncology
- Contact Person Name
- Alejandro Falcón González
- Contact Person Email
- afalconglez@gmail.com
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Contact Person Name
- Ramon Yarza Barrio
- Contact Person Email
- ramon.yarza@startmadrid.com
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- Oncology
- Contact Person Name
- Geórgia Anguera Palacios
- Contact Person Email
- ganguera@santpau.cat
Sponsor
Primary sponsor
- Full Name
- Kura Oncology Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Investigational products
- Investigational Product Name
- KO-2806
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)